Establishment and characterization of prostate organoids from treatment-naïve patients with prostate cancer.
Publication/Presentation Date
1-1-2022
Abstract
Three-dimensional (3D) organoid culture systems are emerging as potential reliable tools to investigate basic developmental processes of human disease, especially cancer. The present study used established and modified culture conditions to report successful generation and characterization of patient-derived organoids from fresh primary tissue specimens of patients with treatment-naïve prostate cancer (PCa). Fresh tissue specimens were collected, digested enzymatically and the resulting cell suspensions were plated in a 3D environment using Matrigel as an extracellular matrix. Previously established 12-factor medium for organoid culturing was modified to create a minimal 5-factor medium. Organoids and corresponding tissue specimens were characterized using transcriptomic analysis, immunofluorescent analysis, and immunohistochemistry. Furthermore, patient-derived organoids were used to assess the drug response. Treatment-naïve patient-derived PCa organoids were obtained from fresh radical prostatectomy specimens. These PCa organoids mimicked the heterogeneity of corresponding parental tumor tissue. Histopathological analysis demonstrated similar tissue architecture and cellular morphology, as well as consistent immunohistochemical marker expression. Also, the results confirmed the potential of organoids as an
Volume
23
Issue
1
First Page
6
Last Page
6
ISSN
1792-1082
Published In/Presented At
Cheaito, K., Bahmad, H. F., Hadadeh, O., Msheik, H., Monzer, A., Ballout, F., Dagher, C., Telvizian, T., Saheb, N., Tawil, A., El-Sabban, M., El-Hajj, A., Mukherji, D., Al-Sayegh, M., & Abou-Kheir, W. (2022). Establishment and characterization of prostate organoids from treatment-naïve patients with prostate cancer. Oncology letters, 23(1), 6. https://doi.org/10.3892/ol.2021.13124
Disciplines
Medicine and Health Sciences
PubMedID
34820005
Department(s)
Department of Medicine, Hematology-Medical Oncology Division
Document Type
Article